Trial Profile
Prevention of Cardiac Dysfunction During Adjuvant Breast Cancer Therapy: A Randomized, Placebo-controlled, 2x2 Factorial, Double Blind Trial of Candesartan and Metoprolol
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 06 Oct 2022
Price :
$35
*
At a glance
- Drugs Candesartan cilexetil (Primary) ; Metoprolol (Primary)
- Indications Heart failure
- Focus Therapeutic Use
- Acronyms PRADA
- 29 Aug 2022 Results of subanalysis of the PRADA trial presented at the ESC Congress 2022 - Annual Congress of the European Society of Cardiology
- 16 May 2021 Results published in the Circulation
- 12 Feb 2016 Primary endpoint of left ventricular ejection fraction has not been met, according to results published in the European Heart Journal.